David Jakabek1, Murat Yücel2, Valentina Lorenzetti2, Nadia Solowij3. 1. Graduate School of Medicine, University of Wollongong, Wollongong, NSW 2522, Australia. 2. Brain & Mental Health Laboratory, Monash Institute of Cognitive and Clinical Neurosciences, School of Psychological Sciences, Monash University, Clayton, VIC, Australia. 3. School of Psychology and Illawarra Health and Medical Research Institute, University of Wollongong, Wollongong, NSW 2522, Australia. nadia@uow.edu.au.
Abstract
RATIONALE: Conflicting evidence exists on the effects of cannabis use on brain white matter integrity. The extant literature has exclusively focused on younger cannabis users, with no studies sampling older cannabis users. OBJECTIVES: We recruited a sample with a broad age range to examine the integrity of major white matter tracts in association with cannabis use parameters and neurodevelopmental stage. METHODS: Regular cannabis users (n = 56) and non-users (n = 20) with a mean age of 32 (range 18-55 years) underwent structural and diffusion MRI scans. White matter was examined using voxel-based statistics and via probabilistic tract reconstruction. The integrity of tracts was assessed using average fractional anisotropy, axial diffusivity and radial diffusivity. Diffusion measures were compared between users and non-users and as group-by-age interactions. Correlations between diffusion measures and age of onset, duration, frequency and dose of current cannabis use were examined. RESULTS: Cannabis users overall had lower fractional anisotropy than healthy non-users in the forceps minor tract only (p = .015, partial eta = 0.07), with no voxel-wise differences observed. Younger users showed predominantly reduced axial diffusivity, whereas older users had higher radial diffusivity in widespread tracts. Higher axial diffusivity was associated with duration of cannabis use in the cingulum angular bundle (beta = 5.00 × 10(-5), p = .003). Isolated higher AD in older cannabis users was also observed. CONCLUSIONS: The findings suggest that exogenous cannabinoids alter normal brain maturation, with differing effects at various neurodevelopmental stages of life. These age-related differences are posited to account for the disparate results described in the literature.
RATIONALE: Conflicting evidence exists on the effects of cannabis use on brain white matter integrity. The extant literature has exclusively focused on younger cannabis users, with no studies sampling older cannabis users. OBJECTIVES: We recruited a sample with a broad age range to examine the integrity of major white matter tracts in association with cannabis use parameters and neurodevelopmental stage. METHODS: Regular cannabis users (n = 56) and non-users (n = 20) with a mean age of 32 (range 18-55 years) underwent structural and diffusion MRI scans. White matter was examined using voxel-based statistics and via probabilistic tract reconstruction. The integrity of tracts was assessed using average fractional anisotropy, axial diffusivity and radial diffusivity. Diffusion measures were compared between users and non-users and as group-by-age interactions. Correlations between diffusion measures and age of onset, duration, frequency and dose of current cannabis use were examined. RESULTS: Cannabis users overall had lower fractional anisotropy than healthy non-users in the forceps minor tract only (p = .015, partial eta = 0.07), with no voxel-wise differences observed. Younger users showed predominantly reduced axial diffusivity, whereas older users had higher radial diffusivity in widespread tracts. Higher axial diffusivity was associated with duration of cannabis use in the cingulum angular bundle (beta = 5.00 × 10(-5), p = .003). Isolated higher AD in older cannabis users was also observed. CONCLUSIONS: The findings suggest that exogenous cannabinoids alter normal brain maturation, with differing effects at various neurodevelopmental stages of life. These age-related differences are posited to account for the disparate results described in the literature.
Entities:
Keywords:
Brain; Cannabis; Diffusion tensor imaging; Magnetic resonance imaging; Tractography; White matter
Authors: J N Giedd; J Blumenthal; N O Jeffries; F X Castellanos; H Liu; A Zijdenbos; T Paus; A C Evans; J L Rapoport Journal: Nat Neurosci Date: 1999-10 Impact factor: 24.884
Authors: Stephen M Smith; Mark Jenkinson; Mark W Woolrich; Christian F Beckmann; Timothy E J Behrens; Heidi Johansen-Berg; Peter R Bannister; Marilena De Luca; Ivana Drobnjak; David E Flitney; Rami K Niazy; James Saunders; John Vickers; Yongyue Zhang; Nicola De Stefano; J Michael Brady; Paul M Matthews Journal: Neuroimage Date: 2004 Impact factor: 6.556
Authors: Lars T Westlye; Kristine B Walhovd; Anders M Dale; Atle Bjørnerud; Paulina Due-Tønnessen; Andreas Engvig; Håkon Grydeland; Christian K Tamnes; Ylva Ostby; Anders M Fjell Journal: Cereb Cortex Date: 2009-12-23 Impact factor: 5.357
Authors: Francesca M Filbey; Sina Aslan; Vince D Calhoun; Jeffrey S Spence; Eswar Damaraju; Arvind Caprihan; Judith Segall Journal: Proc Natl Acad Sci U S A Date: 2014-11-10 Impact factor: 11.205
Authors: Bart D Peters; Toshikazu Ikuta; Pamela DeRosse; Majnu John; Katherine E Burdick; Patricia Gruner; Daniel M Prendergast; Philip R Szeszko; Anil K Malhotra Journal: Biol Psychiatry Date: 2013-07-02 Impact factor: 13.382
Authors: Philip R Szeszko; Joshua Vogel; Manzar Ashtari; Anil K Malhotra; John Bates; John M Kane; Robert M Bilder; Theresa Frevert; Kelvin Lim Journal: Neuroreport Date: 2003-12-19 Impact factor: 1.837
Authors: Saida R Sharapova; Elyse Phillips; Karen Sirocco; Jennifer W Kaminski; Rebecca T Leeb; Italia Rolle Journal: Paediatr Perinat Epidemiol Date: 2018-10-18 Impact factor: 3.980
Authors: Dae-Jin Kim; Ashley M Schnakenberg Martin; Yong-Wook Shin; Hang Joon Jo; Hu Cheng; Sharlene D Newman; Olaf Sporns; William P Hetrick; Eli Calkins; Brian F O'Donnell Journal: Hum Brain Mapp Date: 2018-09-11 Impact factor: 5.038